Work

Phase 1b study of bleximenib in combination with venetoclax in Acute Myeloid Leukemia with KMT2A or NPM1 alterations

Year: 2025
Type: conference-abstract
Source: Blood
Language: English
Subfield: Hematology
Field: Medicine
Open Access status: closed
OpenAlex ID: W4417019776
Cites:
Cited by: 5
Related to: